We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The VR leadless pacemaker: Results of an expert panel using the RAND/UCLA method.
- Authors
Molina‐Linde, Juan Máximo; Díaz‐Infante, Ernesto; Tercedor‐Sánchez, Luis; Baños‐Álvarez, Elena; Piedad‐Rosario, María; Blasco‐Amaro, Juan Antonio
- Abstract
Background: Leadless pacemakers were developed to reduce complications associated with transvenous pacemaker implantation and long‐term follow‐up. Existing international guidelines lack detailed instructions on patients suitable for leadless pacemaker implantation. Our aim was to develop a consensus document that provides medical guidance for all health professionals involved in the indication and implantation of Transcatheter Pacing System single‐chamber device (VR leadless) pacemakers for patients with atrial fibrillation or in sinus rhythm. Methods: A panel of experts, including interventional and non‐interventional cardiologists, used the Research ANd Development/University of California at Los Angeles (RAND/UCLA) method to rate the appropriateness of leadless pacemaker implantation for 64 scenarios in patients with atrial fibrillation and 192 scenarios in sinus rhythm. The scenarios were rated individually and again during a moderated group session. Median ratings and level of agreement were calculated to classify each scenario as appropriate, inappropriate, or questionable. Results: This consensus statement, based on available literature and the experts' opinions, summarizes recommendations for standardizing and optimizing leadless pacemaker implantation. The limitation for vascular access via the superior vena cava was the most influential variable when indicating leadless pacemaker implantation in both patients with atrial fibrillation and patients in sinus rhythm. Conclusions: Life expectancy, risk of infection, prosthetic valve, left ventricular ejection fraction (LVEF), limitation for vascular access via the superior vena cava, and mobility and exercise capacity determine who is advised to undergo VR leadless pacemaker implantation. More prospective studies are needed to optimize existing recommendations.
- Subjects
RISK of prosthesis complications; ATRIAL fibrillation treatment; INFECTION risk factors; CONSENSUS (Social sciences); DECISION trees; VENTRICULAR ejection fraction; EXERCISE tolerance; CARDIOLOGISTS; LIFE expectancy; MEDICAL protocols; ELECTROPHYSIOLOGY; CARDIAC pacing; RISK assessment; DESCRIPTIVE statistics; PHYSICAL mobility; CARDIAC pacemakers
- Publication
Pacing & Clinical Electrophysiology, 2023, Vol 46, Issue 5, p358
- ISSN
0147-8389
- Publication type
Article
- DOI
10.1111/pace.14699